Verition Fund Management’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
22,356
+11,079
| +98% | +$774K | 0.01% | 1588 |
|
|
2025
Q1 | $829K | Buy |
11,277
+5,718
| +103% | +$420K | ﹤0.01% | 1718 |
|
|
2024
Q4 | $364K | Buy |
5,559
+1,222
| +28% | +$80.1K | ﹤0.01% | 2043 |
|
|
2024
Q3 | $338K | Sell |
4,337
-8,404
| -66% | -$655K | ﹤0.01% | 1900 |
|
|
2024
Q2 | $994K | Buy |
12,741
+53
| +0.4% | +$4.13K | 0.01% | 1163 |
|
|
2024
Q1 | $860K | Sell |
12,688
-4,801
| -27% | -$325K | 0.01% | 1210 |
|
|
2023
Q4 | $1.18M | Buy |
+17,489
| New | +$1.18M | 0.01% | 840 |
|
|
2023
Q1 | – | Sell |
-570,288
| Closed | -$38.7M | – | 1960 |
|
|
2022
Q4 | $38.7M | Hold |
570,288
| – | – | 0.6% | 10 |
|
|
2022
Q3 | $31.3M | Buy |
570,288
+567,150
| +18,074% | +$31.1M | 0.35% | 24 |
|
|
2022
Q2 | $207K | Sell |
3,138
-3,741
| -54% | -$247K | ﹤0.01% | 1845 |
|
|
2022
Q1 | $456K | Sell |
6,879
-128,121
| -95% | -$8.49M | 0.01% | 1284 |
|
|
2021
Q4 | $7.86M | Sell |
135,000
-2,537,201
| -95% | -$148M | 0.06% | 158 |
|
|
2021
Q3 | $160M | Buy |
2,672,201
+1,361,481
| +104% | +$81.8M | 1.39% | 5 |
|
|
2021
Q2 | $78.5M | Buy |
1,310,720
+1,210,792
| +1,212% | +$72.5M | 0.71% | 12 |
|
|
2021
Q1 | $4.97M | Sell |
99,928
-288,946
| -74% | -$14.4M | 0.06% | 147 |
|
|
2020
Q4 | $19.4M | Buy |
388,874
+154,631
| +66% | +$7.73M | 0.17% | 50 |
|
|
2020
Q3 | $12.8M | Buy |
234,243
+228,499
| +3,978% | +$12.5M | 0.26% | 41 |
|
|
2020
Q2 | $304K | Buy |
+5,744
| New | +$304K | 0.01% | 719 |
|
|
2020
Q1 | – | Sell |
-881,810
| Closed | -$44M | – | 528 |
|
|
2019
Q4 | $44M | Buy |
881,810
+828,548
| +1,556% | +$41.3M | 0.8% | 11 |
|
|
2019
Q3 | $2.37M | Buy |
+53,262
| New | +$2.37M | 0.07% | 154 |
|
|
2013
Q3 | – | Sell |
-5,572
| Closed | -$264K | – | 500 |
|
|
2013
Q2 | $264K | Buy |
+5,572
| New | +$264K | 0.05% | 365 |
|